Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

ARWR Cash From Investing

Annual CFI

-$129.29M$290.78M+69.22%

Summary

Current Value
As of today, ARWR annual cash from investing is -$129.29M, up +69.22% on
Historical Performance
ARWR annual cash from investing is down -2286.82% over the past 3 years, and up +46.30% over the past 5 years
All-Time High Comparison
ARWR annual cash from investing is currently -1015.63% below its historical high of $14.12M set on
3-Year Low Comparison
ARWR annual cash from investing is +69.22% above its 3-year low of -$420.07M reached on
Sector Comparison
ARWR annual cash from investing is higher than 16.14% of companies in Healthcare sector

Cash From Investing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ARWR Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Investing-$129.29M+69.2%-2286.8%+46.3%-10000.0%
Quarterly Cash From Investing$72.62M+132.6%+99.3%+210.2%+10000.0%
TTM Cash From Investing-$129.29M+69.2%-2286.8%+46.3%-10000.0%
Price$65.55+263.1%+78.0%-20.9%+608.6%
Annual Cash From Operations$179.55M+138.8%+231.9%+288.2%+2432.9%
Annual Cash From Financing$74.01M-91.5%+13.5%-71.3%+514.7%
Annual CAPEX$22.67M-84.0%-57.0%+89.7%+10000.0%
Annual Free Cash Flow$156.89M+126.0%+183.1%+246.2%+2136.9%
Annual Total Assets$1.45B+27.3%+109.6%+177.6%+10000.0%

Cash From Investing Highs

ARWR Annual Cash From Investing Highs Comparison
PeriodHighDateCurrent
3Y-$5.42MN/A-2286.8%
5Y-$5.42M-2286.8%
All$14.12M-1015.6%

Cash From Investing Lows

ARWR Annual Cash From Investing Lows Comparison
PeriodLowDateCurrent
3Y-$420.07M+69.2%
5Y-$420.07M+69.2%
All-$420.07M+69.2%

Cash From Investing History

YearValueChange
-$129.29M+69.2%
-$420.07M-336.9%
-$96.16M-1,675.1%
-$5.42M+96.2%
-$141.68M+41.2%
-$240.78M-404.3%
-$47.75M-542.2%
-$7.44M+84.7%
-$48.64M-461.7%
$13.45M-4.8%
$14.12M+138.7%
-$36.48M-283.2%
-$9.52M-2,261.0%
$440.60K-78.9%
$2.09M+331.0%
YearValueChange
$484.90K-34.4%
$739.10K+128.7%
-$2.57M-158.8%
$4.38M+908.1%
-$542.00K-123.9%
$2.27M+731.1%
-$359.60K>-9,900.0%
-$2,100.00-23.5%
-$1,700.00>-9,900.0%
$0.00+100.0%
-$700.00>-9,900.0%
$0.000.0%
$0.000.0%
$0.00-

FAQ

  • What is the current annual cash from investing of ARWR?

    As of today, ARWR annual cash from investing is -$129.29M

  • What is 1-year change in ARWR annual cash from investing?

    ARWR annual cash from investing is up +69.22% year-over-year

  • What is 3-year change in ARWR annual cash from investing?

    ARWR annual cash from investing is down -2286.82% over the past 3 years

  • How far is ARWR annual cash from investing from its all-time high?

    ARWR annual cash from investing is currently -1015.63% below its historical high of $14.12M set on September 30, 2015

  • How does ARWR annual cash from investing rank versus sector peers?

    ARWR annual cash from investing is higher than 16.14% of companies in Healthcare sector

  • When is ARWR next annual earnings release?

    As of today, the next annual earnings release for ARWR has not been scheduled

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
  3. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  4. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr